...
首页> 外文期刊>Oncology letters >Synergistic effect of ginsenoside Rg3 with verapamil on the modulation of multidrug resistance in human acute myeloid leukemia cells
【24h】

Synergistic effect of ginsenoside Rg3 with verapamil on the modulation of multidrug resistance in human acute myeloid leukemia cells

机译:人参皂苷Rg3与维拉帕米对人急性髓性白血病细胞多药耐药性的协同调节作用

获取原文
获取原文并翻译 | 示例
           

摘要

The pharmacological modulatory effects of 20(S)-ginsenoside Rg3 (20S-Rg3) on multidrug resistant cancer cells are reported in the present study. The effects of 20(S)-Rg3 on the modulation of doxorubicin (DOX) and vincristine (VCR) resistance were examined in the HL60 multidrug resistant subline of human acute myeloid leukemia cells. Results demonstrated that 20S-Rg3 is as effective as verapamil (Vp) for modulating the high degree primary DOX resistance and low degree VCR cross-resistance expressed by the H160 cell line. Furthermore, the present study demonstrates for the first time, using isobologram analysis, that the combination of 20S-Rg3 and Vp enhances the reversal of DOX and VCR resistance in a supra-additive or at least an additive manner. These results indicate that 20S-Rg3 may be used as a Vp synergizer or as a promising alternative to Vp in the chemosensitization of multidrug resistant acute myeloid leukemia, with far fewer side effects.
机译:本研究报道了20(S)-人参皂甙Rg3(20S-Rg3)对多药耐药癌细胞的药理调节作用。在人急性髓性白血病细胞HL60多药耐药亚系中检测了20(S)-Rg3对阿霉素(DOX)和长春新碱(VCR)耐药性调节的影响。结果表明20S-Rg3与维拉帕米(Vp)一样有效,可调节H160细胞株表达的高度原发性DOX耐药性和低度VCR交叉耐药性。此外,本研究首次使用等效线分析法证明,20S-Rg3和Vp的组合以超加性或至少加性方式增强DOX和VCR抵抗力的逆转。这些结果表明20S-Rg3可用作多药耐药性急性髓细胞白血病的化学增敏中的Vp增效剂或Vp的有前途的替代品,副作用少得多。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号